Australia, Dec. 9 -- Neurocrine Biosciences Inc., owns the trademark (2589697) for 'CRINECERFRIENDS' till May 16, 2035.
Status: protected:
Registered/protected
Classes: 9 [Downloadable children's books; downloadable children's booklets; downloadable children's activity books; downloadable newsletters; downloadable computer software games.], 16 [Printed children's books; printed children's booklets; printed activity books; printed newsletters in the field of endocrine diseases and disorders.], 35 [Administering a patient support program to coordinate access to medicines; administering a patient support program to provide pharmaceutical co-pay assistance; administering a patient support program to provide general education and support and information about available resources for patients, caregivers and healthcare providers; administering a patient support program to provide and assist with insurance coverage and reimbursement information; promoting awareness of congenital adrenal hyperplasia including via a public platform to discuss congenital adrenal hyperplasia and coping strategies; promoting awareness of adrenal insufficiency including via a public platform to discuss adrenal insufficiency and coping strategies; promoting awareness of endocrine diseases and disorders including via a public platform to discuss endocrine diseases and disorders and coping strategies; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders.], 38 [Providing an online forum in the field of health and pharmaceuticals.], 41 [Educational services; providing mentorship programs in the field of health and pharmaceuticals; providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; providing an in-person health forum for users to participate in discussions in the field of adrenal insufficiency; providing an in-person health forum for users to participate in discussions in the field of endocrine diseases and disorders.], 42 [Providing information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders; creating an online community for users for the purpose of participating in discussions in the fields of health, pharmaceuticals, and coping strategies.] and 44 [Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders.]
Type of Mark: Word
Date of Acceptance: Sept. 30
Registration Advertised: Dec. 8
For further details contact King & Wood Mallesons and P.C. Nadine H. Jacobson Fross Zelnick Lehrman & Zissu.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2589697.
Disclaimer: Curated by HT Syndication.
